Possible Health Risk due to the Environmental Exposure of High Levels of Lead in Exhaust Soot of Automobiles in Parts of Accra, Ghana

Internal combustion engines produce soot as a result of incomplete gasoline and diesel combustion.  Leaded exhaust soot emitted into the atmosphere has serious health and environmental concerns. Lead has been outlawed as an automotive gasoline additive in most countries including Ghana because of its cumulative toxicity in humans especially children and damaging effect on catalytic converters in automobiles. Nevertheless, leaded fuels are apparently being produced, imported and used illegally in some countries as octane rating booster because of its profitability. Refined gasoline and diesel are imported into Ghana through bulk oil distribution firms. This preliminary study assessed the level of lead in automotive exhaust soot from randomly selected automobiles in parts of Accra. Exhaust soot samples obtained from ten diesel and ten gasoline automobiles were collected for analysis of its lead concentration using atomic absorption spectrophotometry. The results showed the presence of lead in 4(40%) and 10(100%) of the randomly selected diesel and gasoline vehicular exhaust soot respectively. The concentration of lead in the exhaust soot of diesel-powered automobiles ranged from 0.060mg/kg to 0.435mg/kg and that of the gasoline-powered vehicles recorded values ranging from 0.195mg/kg to 2.055mg/kg. With this rather high level of lead in the vehicular soot, it could be concluded that the exhaust soot can be a significant source of lead in the atmosphere in parts of Accra. Lead exposure is known to cause debilitating developmental and neurological effects in children and cardiovascular effects in adults. The high levels of lead in the exhaust soot may be attributed to the possibility of lead additives in the gasoline and diesel used by those automobiles. Regulators of the petroleum downstream industry such as the National Petroleum Authority must routinely test for lead in imported refined petroleum products and enforce the ban on the importation, sale and usage of the outlawed leaded fuel in Ghana. Further studies should be conducted on the levels of lead in air and blood lead levels in fuel dispensers, fuel tanker drivers and fuel loading workers of bulk oil distribution firms. Keywords: Lead, Exhaust, Soot, Gasoline, Automobil

Development and Validation of an RP-HPLC Method for the Quantitative Analysis of Triclosan in Human Urine

Triclosan (TCS), a synthesized chlorinated phenolic compound, is commonly utilized in consumable products as an antimicrobial agent. TCS has sparked widespread awareness because of its toxicity and possible negative effect on public health in recent years. In this study, a highly sensitive, fast, and cost-effective isocratic reversed-phase high-performance liquid chromatography (RP-HPLC) method coupled with solid-phase extraction for analysis of triclosan in human urine samples was developed. The method utilized methanol and water in a ratio of 90 : 10 as the mobile phase on a Phenomenex Luna 3 µm C18(2) 100 Å, 150 × 4.60 mm stationary phase, with a runtime of 5 minutes. The method showed good resolution of triclosan in the presence of the sample matrix. Validation of the method was performed according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Linearity was tested over a range of 0.00625 µg/mL to 6.4 µg/mL, as accuracy recorded a recovery of 89.25%, 91.0%, and 92.75%. Limits of detection (LOD) and quantification (LOQ) were obtained to be 0.0173 µg/mL and 0.0525 µg/mL, respectively. The method proved to be robust over a temperature range of 26°C, 30°C, and 35°C and a flow rate of 0.5 ml, 1.0 ml, and 1.5 ml. The developed method was employed to detect and quantify triclosan in 153 urine samples, comprising 60 samples from Ibadan, Nigeria, and 93 samples from Kumasi, Ghana. Triclosan was detected in a total of 52 samples with an average content of 0.054588 µg/ml. This method can therefore be used for the routine analysis of triclosan in urine samples

Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana.

BACKGROUND: Global surveillance for vaccine preventable invasive bacterial diseases has been set up by the World Health Organization to provide disease burden data to support decisions on introducing pneumococcal conjugate vaccine (PCV). We present data from 2010 to 2016 collected at the 2 sentinel sites in Ghana. METHODS: Data were collected from children <5 years of age presenting at the 2 major teaching hospitals with clinical signs of meningitis. Cerebrospinal fluid specimens were collected and tested first at the sentinel site laboratory with conventional microbiology methods and subsequently with molecular analysis, at the World Health Organization Regional Reference Laboratory housed at the Medical Research Council Unit The Gambia, for identification of Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, the 3 most common bacteria causing meningitis. RESULTS: There were 4008 suspected cases of meningitis during the surveillance period, of which 31 (0.8%) were laboratory confirmed. Suspected meningitis cases decreased from 923 in 2010 to 219 in 2016. Of 3817 patients with available outcome data, 226 (5.9%) died. S. pneumoniae was the most common bacterial pathogen, accounting for 68.5% of confirmed cases (50 of 73). H. influenzae and N. meningitidis accounted for 6.8% (5 of 73) and 21.9% (16 of 73), respectively. The proportion of pneumococcal vaccine serotypes causing meningitis decreased from 81.3% (13 of 16) before the introduction of 13-valent PCV (2010-2012) to 40.0% (8 of 20) after its introduction (2013-2016). CONCLUSIONS: Cases of suspected meningitis decreased among children <5 years of age between 2010 and 2016, with declines in the proportion of vaccine-type pneumococcal meningitis after the introduction of 13-valent PCV in Ghana

Snail Based Carbonated-Hydroxyapatite Material as Adsorbents for Water Iron (II)

Carbonated hydroxyapatite (CHAp) adsorbent material was prepared from Achatina achatina snail shells and phosphate-containing solution using a wet chemical deposition method. The CHAp adsorbent material was investigated to adsorb aqua Fe(II) complex; [Fe(H₂O)₆]²⁺ from simulated iron contaminated water for potential iron remediation application. The CHAp was characterized before and after adsorption using infrared (IR) and Raman spectroscopy. The IR and the Raman data revealed that the carbonate functional groups of the CHAp adsorbent material through asymmetric orientation in water bonded strongly to the aqua Fe(II) complex adsorbate. The adsorption behaviour of the adsorbate onto the CHAp adsorbent correlated well to pseudo-second-order kinetics model, non-linear Langmuir and Freundlich model at room temperature of a concentration (20–100 mg L -¹) and contact time of 180 min. The Langmuir model estimated the maximum adsorption capacity to be 45.87 mg g -¹ whereas Freundlich model indicated an S-type isotherm curvature which supported the spectroscopy revelation.Applied Science, Faculty ofNon UBCChemical and Biological Engineering, Department ofReviewedFacult

Development and Validation of an RP-HPLC Method for the Quantitative Analysis of Triclosan in Human Urine

Funder: National Institute for Health Research; doi: http://dx.doi.org/10.13039/501100000272Triclosan (TCS), a synthesized chlorinated phenolic compound, is commonly utilized in consumable products as an antimicrobial agent. TCS has sparked widespread awareness because of its toxicity and possible negative effect on public health in recent years. In this study, a highly sensitive, fast, and cost-effective isocratic reversed-phase high-performance liquid chromatography (RP-HPLC) method coupled with solid-phase extraction for analysis of triclosan in human urine samples was developed. The method utilized methanol and water in a ratio of 90 : 10 as the mobile phase on a Phenomenex Luna 3 µm C18(2) 100 Å, 150 × 4.60 mm stationary phase, with a runtime of 5 minutes. The method showed good resolution of triclosan in the presence of the sample matrix. Validation of the method was performed according to the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). Linearity was tested over a range of 0.00625 µg/mL to 6.4 µg/mL, as accuracy recorded a recovery of 89.25%, 91.0%, and 92.75%. Limits of detection (LOD) and quantification (LOQ) were obtained to be 0.0173 µg/mL and 0.0525 µg/mL, respectively. The method proved to be robust over a temperature range of 26°C, 30°C, and 35°C and a flow rate of 0.5 ml, 1.0 ml, and 1.5 ml. The developed method was employed to detect and quantify triclosan in 153 urine samples, comprising 60 samples from Ibadan, Nigeria, and 93 samples from Kumasi, Ghana. Triclosan was detected in a total of 52 samples with an average content of 0.054588 µg/ml. This method can therefore be used for the routine analysis of triclosan in urine samples